Roberto Dinami
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Multi-omics analyses integration reveals a novel TRF2-miR-181a-5p-S100A10 regulatory axis in colon cancer.
Journal: Cellular & molecular biology letters
Published: January 31, 2025
Modulating TERRA G-quadruplexes with ligands: impact on telomeric DNA:RNA hybrids and ALT mechanisms.
Journal: Nucleic acids research
Published: January 07, 2025
TRF2 as novel marker of tumor response to taxane-based therapy: from mechanistic insight to clinical implication.
Journal: Journal of experimental & clinical cancer research : CR
Published: December 27, 2023
The new world of RNA diagnostics and therapeutics.
Journal: Journal of experimental & clinical cancer research : CR
Published: June 16, 2023
MiR-182-3p targets TRF2 and impairs tumor growth of triple-negative breast cancer.
Journal: EMBO molecular medicine
Published: March 18, 2022
TRF2 cooperates with CTCF for controlling the oncomiR-193b-3p in colorectal cancer.
Journal: Cancer letters
Published: November 09, 2021
TRF2 and VEGF-A: an unknown relationship with prognostic impact on survival of colorectal cancer patients.
Journal: Journal of experimental & clinical cancer research : CR
Published: April 10, 2020
TRF2 positively regulates SULF2 expression increasing VEGF-A release and activity in tumor microenvironment.
Journal: Nucleic acids research
Published: December 20, 2018
SFPQ and NONO suppress RNA:DNA-hybrid-related telomere instability.
Journal: Nature communications
Published: January 29, 2018
Epigenetic silencing of miR-296 and miR-512 ensures hTERT dependent apoptosis protection and telomere maintenance in basal-type breast cancer cells.
Journal: Oncotarget
Published: August 17, 2016
Altered telomere homeostasis and resistance to skin carcinogenesis in Suv39h1 transgenic mice.
Journal: Cell cycle (Georgetown, Tex.)
Published: March 20, 2015
Last Updated: 09/26/2026